Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial-Reference-Cited by-同舟云学术

Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial

Published:2014-02 Issue:2 Volume:146 Page:430-441.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Zeuzem Stefan,Berg Thomas,Gane Edward,Ferenci Peter,Foster Graham R.,Fried Michael W.,Hezode Christophe,Hirschfield Gideon M.,Jacobson Ira,Nikitin Igor,Pockros Paul J.,Poordad Fred,Scott Jane,Lenz Oliver,Peeters Monika,Sekar Vanitha,De Smedt Goedele,Sinha Rekha,Beumont-Mauviel Maria

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. World Health Organization. WHO Fact Sheet 164-Hepatitis C. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed June 20, 2013.

2. Hepatitis C therapy update;Casey;Curr Opin Gastroenterol,2012

3. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007;Ly;Ann Intern Med,2012

5. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;McHutchison;N Engl J Med,2009

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferred Therapy for Specific Viral Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-14

2. Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis;Nature Communications;2023-11-17

3. Preferred Therapy for Specific Viral Pathogens;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01

4. Curing Hepatitis C with Direct‐Acting Antiviral Therapy;New Drug Development for Known and Emerging Viruses;2021-12-03

5. Chronic Hepatitis C;Clinical Cases in Hepatology;2021-10-26